Functional status in older patients with cancer

Author(s):  
Anne-Laure Couderc ◽  
Pierre Suchon ◽  
Bérengère Saliba-Serre ◽  
Dominique Rey ◽  
Emilie Nouguerede ◽  
...  
Author(s):  
Ann Helen Torstveit ◽  
Christine Miaskowski ◽  
Borghild Løyland ◽  
Ellen Karine Grov ◽  
Marianne Grønlie Guren ◽  
...  

2014 ◽  
Vol 5 ◽  
pp. S75
Author(s):  
R. Kandel ◽  
J. Benerjee ◽  
S. Thakur ◽  
V. Kumar ◽  
H. Bhatti ◽  
...  

2005 ◽  
Vol 23 (13) ◽  
pp. 3112-3124 ◽  
Author(s):  
Carol A. Townsley ◽  
Rita Selby ◽  
Lillian L. Siu

Purpose Older patients are significantly underrepresented in cancer clinical trials. A literature review was undertaken to identify the barriers that impede the accrual of this vulnerable population onto clinical trials and to determine what specific strategies are needed to improve the representation of older patients in research studies. Methods A systematic literature search was undertaken using several different strategies to identify relevant articles. Results Nine of 31 relevant papers from 159 citations were included. Age is a significant barrier to recruitment; only a quarter to one third of potentially eligible older patients are enrolled onto trials. Physicians' perceptions, protocol eligibility criteria with restrictions on comorbid conditions, and functional status to optimize treatment tolerability are the most important reasons resulting in the exclusion of older patients. Other barriers include the lack of social support and the need for extra time and resources to enroll these patients. Conversely, older patients do not view their age as an important reason for refusing trials. Conclusion Specific clinical trials confined to older patients should be conducted to evaluate tumor biology, treatment tolerability, and the effect of comorbid conditions. Protocol designs need to stratify for age and be less restrictive with respect to exclusions on functional status, comorbidity, and previous cancers, such that results are generalizable to older patients. Physician education to dispel unfounded perceptions, improved access to available clinical trials, and provision of personnel and resources to accommodate the unique requirements of an older population are possible solutions to remove the barriers of ageism.


2018 ◽  
Vol 2018 ◽  
pp. 1-7
Author(s):  
Somayeh Fahimnia ◽  
Hadi Mirhedayati Roudsari ◽  
John Doucette ◽  
Armin Shahrokni

Falls are common among older adults. However, not much is known about the prevalence of falls among older patients with cancer. In 2015, older patients with cancer referred to Geriatrics service for preoperative evaluation were assessed for fall history, basic and instrumental activities of daily living (ADL and IADL), KPS, and use of assistive device. Of 806 patients, 215 (26.7%) patients reported fall. Incidence of last fall inside and outside home was 54.4% and 45.5%, respectively. Among patients with no falls, 33.6% had KPS ≤ 80 compared to 59.6% with one-time fall and 60.7% with multiple falls (p<0.001). Among IADL, 8.5% of patients with no falls were unable to do shopping compared with 14.7% in one-time fall and 18.8% in multiple fallers (p<0.001). In ADL items, the percentage of patients who were limited a lot in walking outside was 10.7% in no falls, 20.2% in one-time fall, and 27.1% in multiple fallers groups (p<0.001). Only 17.8% of patients with no falls were using canes while 27.7% of patients with one-time fall and 38.8% with multiple falls were using canes (p<0.001). Falls are prevalent among older patients with cancer. Fall history and number of falls are associated with functional status.


Sign in / Sign up

Export Citation Format

Share Document